Cargando…

Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series

BACKGROUND: Glucagon-like peptide-1 receptor agonists have been reported to reduce body fat as well as improving glycemic control in obese patients with type 2 diabetes. However, the maximum dose of liraglutide is limited to 0.9 mg in Japan, while the international dose is 1.8 mg; and the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishii, Satoshi, Nagai, Yoshio, Sada, Yukiyoshi, Fukuda, Hisashi, Nakamura, Yuta, Matsuba, Ren, Nakagawa, Tomoko, Kato, Hiroyuki, Tanaka, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396779/ https://www.ncbi.nlm.nih.gov/pubmed/30834046 http://dx.doi.org/10.14740/jocmr3647

Ejemplares similares

Proposed cut‐off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population
por: Tsukiyama, Hidekazu, et al.
Publicado: (2016)

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes
por: Ishii, Satoshi, et al.
Publicado: (2020)

Differing Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. Lean Mass in Patients With or Without Metformin Therapy
por: Nagai, Yoshio, et al.
Publicado: (2019)

Tofogliflozin decreases body fat mass and improves peripheral insulin resistance
por: Matsuba, Ren, et al.
Publicado: (2018)

Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia
por: Ohta, Akio, et al.
Publicado: (2017)

Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes
por: Uchiyama, Syutaro, et al.
Publicado: (2023)

Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study
por: Hishida, Yoshiaki, et al.
Publicado: (2022)

Short-term change of carotid intima-media thickness after treatment of hyperglycemia in patients with diabetes: a cross-sectional study
por: Tenjin, Ayumi, et al.
Publicado: (2016)

Estimating Visceral Fat Area by Multifrequency Bioelectrical Impedance
por: Nagai, Masato, et al.
Publicado: (2010)

Weight reduction is associated with improvement of glycemic control in Japanese men, whose hemoglobin A1C is 5.6–6.4%, with visceral fat accumulation, but not without visceral fat accumulation
por: Okauchi, Yukiyoshi, et al.
Publicado: (2013)

Intrahepatic lipid, not visceral or muscle fat, is correlated with insulin resistance in older, female Rhesus macaques
por: Chu, Michael P, et al.
Publicado: (2013)

Efficacy and safety of switching from basal insulin to once‐daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetes: A 4‐week, randomized, open‐label, treat‐to‐target study
por: Nagai, Yoshio, et al.
Publicado: (2017)

Predictors of deterioration of glucose tolerance and effects of lifestyle intervention aimed at reducing visceral fat in normal glucose tolerance subjects with abdominal obesity
por: Akita, Etsuko F, et al.
Publicado: (2010)

Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study
por: Okauchi, Yukiyoshi, et al.
Publicado: (2011)

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
por: Inoue, Kana, et al.
Publicado: (2011)

The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Gioia, Stefania, et al.
Publicado: (2021)

Visceral and subcutaneous fat
por: Lederman, Henrique Manoel
Publicado: (2014)

Extent of weight reduction necessary for minimization of diabetes risk in Japanese men with visceral fat accumulation and glycated hemoglobin of 5.6–6.4%
por: Iwahashi, Hiromi, et al.
Publicado: (2015)

Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation
por: Murai, Jun, et al.
Publicado: (2018)

Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30
por: Ohta, Akio, et al.
Publicado: (2011)

Post-operative depletion of platelet count is associated with anastomotic insufficiency following intrahepatic cholangiojejunostomy: a case–control study from the results of 220 cases of intrahepatic cholangiojejunostomy
por: Noji, Takehiro, et al.
Publicado: (2014)

Evaluation of visceral fat mass in dogs by computed tomography
por: NAGAO, Itsuma, et al.
Publicado: (2019)

Characteristics of Gut Microbiota in Patients With Diabetes Determined by Data Mining Analysis of Terminal Restriction Fragment Length Polymorphisms
por: Nakamura, Yuta, et al.
Publicado: (2019)

Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression
por: Shao, Yimin, et al.
Publicado: (2015)

Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects
por: Obata, Yoshinari, et al.
Publicado: (2016)

Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?
por: Kawata, Takehiro, et al.
Publicado: (2014)

Visceral Fat Accumulation Is Associated with Asthma in Patients with Type 2 Diabetes
por: Murakami, Daisuke, et al.
Publicado: (2019)

Association between Serum Concentration of Carotenoid and Visceral Fat
por: Matsumoto, Mai, et al.
Publicado: (2021)

Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease
por: Furutate, Ryuko, et al.
Publicado: (2011)

Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism
por: Shibayama, Yui, et al.
Publicado: (2018)

Relationships of rapid eating with visceral and subcutaneous fat mass and plasma adiponectin concentration
por: Tsumura, Hideki, et al.
Publicado: (2023)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

Visceral Fat Area and Markers of Insulin Resistance in Relation to Colorectal Neoplasia
por: Yamamoto, Shuichiro, et al.
Publicado: (2010)

A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells
por: Yamaoka, Masaya, et al.
Publicado: (2012)

Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis
por: Liang, Riying, et al.
Publicado: (2020)

Measurement of Visceral Fat: Should We Include Retroperitoneal Fat?
por: Hung, Chi-Sheng, et al.
Publicado: (2014)

MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice
por: Ferrigno, Andrea, et al.
Publicado: (2023)

Comparison of anterior knee laxity immediately after anatomic double-bundle anterior cruciate ligament reconstruction: Manual tensioning vs tensioning boot techniques
por: Mae, Tatsuo, et al.
Publicado: (2022)

Visceral fat and cardiorespiratory fitness with prevalence of pre-diabetes/diabetes mellitus among middle-aged and elderly Japanese people: WASEDA’S Health Study
por: Usui, Chiyoko, et al.
Publicado: (2020)

SAT-002 Measurement of Visceral Fat Using Computed Tomography in Two Subtypes of Primary Aldosteronism
por: Shibayama, Yui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rc50k05to3idm25mr215t2b442